SCHEMBL1226763

SCHEMBL1226763

COc1ccc(-c2ccc(/C=C3/N=C(N)N(Cc4ccc(CCc5ccccc5)cc4)C3=O)o2)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTRA2 O43464 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.43
▸ MAPT P10636 6/20 0.43
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ POLB P06746 3/20 0.43
▸ NPSR1 Q6W5P4 3/20 0.43
▸ MCL1 Q07820 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ PTPN7 P35236 1/20 0.43
▸ PTPN12 Q05209 1/20 0.43
▸ PTPN22 Q9Y2R2 1/20 0.43
▸ TDP1 Q9NUW8 3/20 0.42
▸ RECQL P46063 2/20 0.42
▸ EIF4E P06730 1/20 0.42
▸ EIF4G1 Q04637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ PRKAG1 P54619 1/20 0.42
▸ PRKAA2 P54646 1/20 0.42
▸ PRKAB1 Q9Y478 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1226764 1.00 HTRA2 (0.54) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1116267 0.97 HTRA2 (0.57) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1116263 0.97 HTRA2 (0.57) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1228315 0.91 HTRA2 (0.53) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1228316 0.91 HTRA2 (0.53) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1227354 0.91 MAPT (0.50) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1227358 0.91 MAPT (0.50) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1228130 0.90 HTRA2 (0.50) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1228131 0.90 HTRA2 (0.50) HTRA2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1228294 0.89 HTRA2 (0.49) HTRA2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
Send feedback